MassMutual Disciplined Value R4 (MPIRX)
13.25
-0.01 (-0.08%)
USD |
May 24 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 1.19% | 79.44M | 1.05% | 189.0% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -23.58M | -0.01% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks long-term total return. The fund invests primarily in equity securities of U.S. large- and mid-cap companies. It currently invests substantially all of its assets in companies represented in the Russell 1000® Value Index at the time of purchase, although the fund is actively managed and is not an index fund or a passively managed investment. The fund may hold a portion of its assets in unlisted securities. It may invest in exchange-traded funds and may use equity index futures contracts as a substitute for direct investments in order to help manage cash flows. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | DENVX |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | MassMutual |
| Prospectus Benchmark Index | |
| Russell 1000 Value TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Thomas Simon | 1.45 yrs |
| Matt Kyller | 1.24 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
53
-23.58M
-4.342B
Category Low
19.90B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of April 30, 2022
Performance Versus Category
As of May 23, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of May 23, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| UnitedHealth Group Inc | 3.21% | 498.00 | 1.20% |
| JPMorgan Chase & Co | 2.73% | 126.00 | 1.12% |
| Pfizer Inc | 2.19% | 53.44 | 1.06% |
| Walmart Inc | 2.00% | 124.08 | 1.21% |
| Bristol-Myers Squibb Co | 1.97% | 77.09 | 0.51% |
| Procter & Gamble Co | 1.97% | 147.76 | 1.86% |
| Thermo Fisher Scientific Inc | 1.94% | 548.42 | -1.22% |
| Danaher Corp | 1.79% | 252.36 | -0.30% |
| Philip Morris International Inc | 1.67% | 106.70 | 3.68% |
| Raytheon Technologies Corp | 1.54% | 93.18 | 1.47% |
Basic Info
| Investment Strategy | |
| The investment seeks long-term total return. The fund invests primarily in equity securities of U.S. large- and mid-cap companies. It currently invests substantially all of its assets in companies represented in the Russell 1000® Value Index at the time of purchase, although the fund is actively managed and is not an index fund or a passively managed investment. The fund may hold a portion of its assets in unlisted securities. It may invest in exchange-traded funds and may use equity index futures contracts as a substitute for direct investments in order to help manage cash flows. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | DENVX |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | MassMutual |
| Prospectus Benchmark Index | |
| Russell 1000 Value TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Thomas Simon | 1.45 yrs |
| Matt Kyller | 1.24 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (5-23-22) | 1.05% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 15.62 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of March 31, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 4/1/2014 |
| Last Annual Report Date | 9/30/2021 |
| Last Prospectus Date | 2/1/2022 |
| Share Classes | |
| DENVX | S |
| MEPAX | A |
| MEPSX | Retirement |
| MPILX | Other |
| MPINX | Retirement |
| MPIVX | Inst |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |